Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

SNN | Smith & Nephew plc

Index- P/E50.94 EPS (ttm)0.50 Insider Own0.60% Shs Outstand436.55M Perf Week-3.93%
Market Cap11.16B Forward P/E- EPS next Y- Insider Trans0.00% Shs Float217.58M Perf Month-5.85%
Income218.00M PEG- EPS next Q- Inst Own9.80% Short Float / Ratio0.80% / 2.28 Perf Quarter-18.63%
Sales5.35B P/S2.09 EPS this Y-57.30% Inst Trans8.81% Short Interest1.75M Perf Half Y-10.90%
Book/sh11.99 P/B2.12 EPS next Y- ROA2.10% Target Price34.33 Perf Year6.63%
Cash/sh0.43 P/C58.76 EPS next 5Y-8.00% ROE4.10% 52W Range21.77 - 33.08 Perf YTD-5.47%
Dividend0.75 P/FCF507.45 EPS past 5Y-22.50% ROI5.30% 52W High-23.17% Beta0.64
Dividend %2.95% Quick Ratio0.80 Sales past 5Y1.80% Gross Margin70.00% 52W Low16.74% ATR0.38
Employees19000 Current Ratio2.20 Sales Q/Q5.20% Oper. Margin9.00% RSI (14)25.67 Volatility1.15% 1.10%
OptionableYes Debt/Eq0.58 EPS Q/Q-15.50% Profit Margin4.10% Rel Volume1.56 Prev Close25.80
ShortableYes LT Debt/Eq0.50 EarningsAug 03 BMO Payout89.00% Avg Volume765.76K Price25.42
Recom2.00 SMA20-4.32% SMA50-10.03% SMA200-12.54% Volume1,197,758 Change-1.47%
Date Action Analyst Rating Change Price Target Change
Aug-08-23Upgrade UBS Sell → Neutral
Apr-27-23Downgrade HSBC Securities Buy → Hold
Apr-11-23Upgrade Morgan Stanley Equal-Weight → Overweight
Dec-12-22Initiated Citigroup Buy
Nov-28-22Downgrade UBS Neutral → Sell
Oct-18-22Initiated Morgan Stanley Equal-Weight
Jul-28-22Downgrade Canaccord Genuity Buy → Hold $40 → $32
Mar-16-22Initiated RBC Capital Mkts Outperform $1700
Mar-15-22Initiated RBC Capital Mkts Outperform
Mar-04-22Upgrade Redburn Sell → Neutral
Sep-21-23 08:24PM
Sep-18-23 11:30AM
Sep-13-23 09:40AM
Sep-04-23 09:40AM
09:25PM Loading…
Jul-05-23 09:25PM
Jun-17-23 08:00AM
Jun-14-23 05:00PM
Jun-12-23 10:00AM
Jun-07-23 01:10AM
May-16-23 08:00AM
May-02-23 08:00AM
Apr-25-23 09:21AM
Apr-24-23 08:00AM
Apr-14-23 09:40AM
07:00PM Loading…
Apr-10-23 07:00PM
Apr-09-23 03:59AM
Mar-29-23 09:40AM
Mar-26-23 03:22AM
Mar-24-23 07:49AM
Mar-23-23 08:00AM
Mar-09-23 07:48AM
Mar-08-23 02:46PM
Mar-07-23 10:00AM
Mar-06-23 09:40AM
Feb-27-23 10:49PM
09:40AM Loading…
Feb-24-23 01:05PM
Feb-23-23 12:00PM
Feb-21-23 09:53AM
Jan-30-23 08:00AM
Jan-24-23 02:34PM
Jan-23-23 09:33AM
Jan-12-23 01:05AM
Jan-04-23 08:00PM
Jan-03-23 08:12PM
Dec-16-22 09:21AM
Dec-08-22 03:51AM
Nov-24-22 03:24AM
Nov-20-22 03:48PM
Nov-09-22 09:36AM
Nov-08-22 11:00PM
Nov-01-22 08:00AM
Oct-18-22 07:25AM
Oct-17-22 10:29AM
Oct-12-22 02:10PM
Oct-11-22 07:26PM
Sep-26-22 02:01PM
Sep-21-22 08:00AM
Sep-19-22 07:00PM
Sep-14-22 12:24PM
Sep-12-22 04:30AM
Aug-09-22 01:00AM
Aug-05-22 01:27AM
Aug-04-22 08:00AM
Jul-28-22 03:30PM
Jul-13-22 08:00AM
Jul-12-22 03:00AM
Jun-30-22 08:00AM
Jun-27-22 04:38AM
Jun-14-22 03:00AM
Jun-08-22 08:00AM
May-29-22 04:36AM
May-11-22 04:31AM
Apr-30-22 06:29AM
Apr-11-22 04:29PM
Apr-08-22 10:15AM
Apr-07-22 08:30AM
Apr-06-22 10:15AM
Apr-05-22 10:15AM
Apr-04-22 11:50AM
Mar-31-22 01:28PM
Mar-29-22 08:30AM
Mar-28-22 08:30AM
Mar-24-22 11:15AM
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. The company operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products, including instruments, technologies, and implants to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.